AI continued to be shown as an invaluable tool with the potential to accelerate clinical trials and improve patient care.

From GLP-1RA and HIV PrEP successes, to flops in DMD and Alzheimer’s, Clinical Trials Arena rounds up the biggest trial read ...

all in one place with Analyst Top Stocks Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter CStone Pharmaceuticals has submitted a clinical trial application in ...

The latest announcement is out from Cingulate Inc ( (CING) ).

H.C. Wainwright initiated coverage of enGene (ENGN) with a Buy rating and $25 price target. The firm says the non-muscle ...

Perspective Therapeutics is a biotech company with promising oncology applications in radiopharmaceuticals. Find out why I ...

Learn about Ionis Pharmaceuticals' innovative RNA-targeted therapy and their potential for significant revenue growth. Read ...

Big Data Analytics in Healthcare Market Predictive analytics drives the healthcare big data market, analyzing patient records, lab resul ...

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Telomir-1 shows potential as a treatment for Wilson's disease and related disorders, with promising preclinical results and ...

Health Enterprise Partners ("HEP"), a healthcare private equity firm, is pleased to announce the promotion of David Rauber to Vice ...